Skip to main content
|

Royal visit to UHB vaccination hub at the ITM

Their Royal Highnesses The Prince of Wales and The Duchess of Cornwall visited the COVID-19 vaccination centre for University Hospitals Birmingham NHS Foundation Trust (UHB) staff on February 17 2021.

Their Royal Highnesses, joined by The Right Honourable Matt Hancock MP, Secretary of State for Health and Social Care, visited the hub here at the Institute of Translational Medicine with key members of the UHB vaccine research team, vaccine rollout team, and members of the public who have taken part in COVID-19 vaccine research in the West Midlands. They also saw people in the top four priority groups receiving their first dose of the vaccine.

Dr David Rosser, Chief Executive Officer at UHB, said: “The Trust is working with our colleagues at Birmingham and Solihull Clinical Commissioning Group, GP partners, pharmacies, Millennium Point and Aston Villa Football Club on the continued successful rollout of the COVID-19 vaccine programme. To date, hundreds of thousands of people across Birmingham and Solihull have received their first dose. As supply increases and eligibility widens, we are looking forward to vaccinating more people and bringing us closer on the path back to normal life.”

Safe and effective vaccines were developed in record time thanks to vaccine research which began in early 2020. The vaccine developed by the University of Oxford and Astrazeneca, one of two currently in use in the UK, was trialled on more than 20,000 people in 2020.

Recruitment to the Oxford vaccine trial was led in the West Midlands by UHB, with almost 1,000 people taking part in vaccine research in the region – the highest total of any area in the country.

Dr Chris Green, UHB Consultant in Infectious Diseases and the trial lead in the West Midlands, said: “The rollout of vaccines is only possible because of the help of the many members of the public who were willing to take part in clinical trials.

“Thanks to them, the successful results are now leading to a wider rollout which will result in protection for the public, and a reduction in the risk of the disease that will allow us to return to a more normal world.

“Alongside the rollout, vaccine research continues with recruitment to new trials, including the testing of other vaccines and the potential to mix and match already approved vaccines.”

Health Secretary, Matt Hancock said: “I was delighted to visit the Queen Elizabeth Hospital in Birmingham alongside their Royal Highnesses the Prince of Wales and the Duchess of Cornwall, and to thank the staff for their heroic efforts throughout the pandemic.

“From treating those suffering from COVID-19 to recruiting record numbers of patients to take part in vaccine clinical trials, each and every one of those working on the frontline has played an incredible role in our nationwide fight against this virus.

“The University Hospitals Birmingham NHS Foundation Trust has played a vital part in helping us reach our target to vaccinate the top four priority groups by mid-February, delivering over 200,000 doses of the vaccine to the most vulnerable people in their community – a truly fantastic achievement.

“There is still more to do, and I urge anyone eligible for the vaccine to come forward and take up their appointment.”

More updates

brain injury

Traumatic brain injuries can increase risk of stroke for up to five years

09/04/2021
Stroke risk for patients with traumatic brain injuries is at its highest in the four months following injury and remains significant for up to five years post-injury, finds a new systematic review led by a team at the University of Birmingham. Traumatic brain injury (TBI) is a global health problem affecting over 60 million people a year worldwide. Incidences of TBI are rising due to a range of…

Rugby study identifies new method to diagnose concussion using saliva

24/03/2021
A study of top-flight UK rugby players – carried out by the University of Birmingham in collaboration with the Rugby Football Union (RFU), Premiership Rugby, and Marker Diagnostics – has identified a method of accurately diagnosing concussion using saliva, paving the way for the first non-invasive clinical test for concussion for use in sport and other settings. Following the team’s previous re…

COVID at home: ‘virtual ward’ app designed in Midlands

23/02/2021
A digital remote care solution including a mobile phone app is helping Covid-19 patients manage their symptoms at home after being developed with the support the West Midlands Academic Health Science Network (WMAHSN). The app developed by medical software company, Dignio, has been implemented by Dudley CCG and allows patients stay at home safely, thus avoiding unnecessary admissions to hospital…

High-performance, low-cost ventilator project awarded grant of £768K by UKRI

11/12/2020
An international team of scientists and engineers have been awarded a grant of £768K by UKRI as part of the Newton Fund’s Agile Response Call to develop high performance, low cost ventilators for use in low to middle income countries, it has been announced today. Prompted by a shortage of ventilators in low income countries highlighted by the COVID-19 pandemic, the HPLV project aims to reengin…

Chemical engineering expertise helps in fight against COVID-19

03/12/2020
From hand sanitisers and nasal sprays to improved PPE, the University of Birmingham’s School of Chemical Engineering and Healthcare Technologies Institute (based here in the ITM) have made significant contributions to the global response to the COVID-19 pandemic. In March, staff set up a manufacturing facility at the Collaborative Teaching Laboratory to produce hand sanitiser, desp…

Featured Articles